Tag: Glaxosmithkline
GSK, PATH & Bharat Biotech sign product transfer agreement over malaria...
Bharat Biotech to produce antigen for world’s first vaccine against Plasmodium falciparum malaria following technology transfer, to help ensure long-term sustainable supply. Transfer builds on GSK commitments to donate up to 10 million vaccine doses.......................
Bharat Biotech set to acquire Chiron Behring Vaccines from GSK
The Ankleshwar, Gujarat based Chiron Behring Vaccines which is a part of GlaxoSmithKline Asia will be acquired by Bharat Biotech in an all cash transaction, subject to a number of closing conditions which both the parties intend to complete in the coming weeks................